Ridker PM - Search Results

1

Novel locus including FGF21 is associated with dietary macronutrient intake.

Chu AY, Workalemahu T, Paynter NP, Rose LM, Giulianini F, Tanaka T, Ngwa JS; CHARGE Nutrition Working Group; Qi Q, Curhan GC, Rimm EB, Hunter DJ, Pasquale LR, Ridker PM, Hu FB, Chasman DI, Qi L; DietGen Consortium. Chu AY, et al. Among authors: ridker pm. Hum Mol Genet. 2013 May 1;22(9):1895-902. doi: 10.1093/hmg/ddt032. Epub 2013 Jan 30. Hum Mol Genet. 2013. PMID: 23372041 Free PMC article.

2

Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction.

Hines LM, Stampfer MJ, Ma J, Gaziano JM, Ridker PM, Hankinson SE, Sacks F, Rimm EB, Hunter DJ. Hines LM, et al. Among authors: ridker pm. N Engl J Med. 2001 Feb 22;344(8):549-55. doi: 10.1056/NEJM200102223440802. N Engl J Med. 2001. PMID: 11207350 Free article.

3

Stability of novel plasma markers associated with cardiovascular disease: processing within 36 hours of specimen collection.

Pai JK, Curhan GC, Cannuscio CC, Rifai N, Ridker PM, Rimm EB. Pai JK, et al. Among authors: ridker pm. Clin Chem. 2002 Oct;48(10):1781-4. Clin Chem. 2002. PMID: 12324497 No abstract available.

4

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.

Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Ridker PM, et al. N Engl J Med. 2002 Nov 14;347(20):1557-65. doi: 10.1056/NEJMoa021993. N Engl J Med. 2002. PMID: 12432042 Free article.

5

Polymorphism in the P-selectin and interleukin-4 genes as determinants of stroke: a population-based, prospective genetic analysis.

Zee RY, Cook NR, Cheng S, Reynolds R, Erlich HA, Lindpaintner K, Ridker PM. Zee RY, et al. Among authors: ridker pm. Hum Mol Genet. 2004 Feb 15;13(4):389-96. doi: 10.1093/hmg/ddh039. Epub 2003 Dec 17. Hum Mol Genet. 2004. PMID: 14681304

6

Pharmacogenetic study of statin therapy and cholesterol reduction.

Chasman DI, Posada D, Subrahmanyan L, Cook NR, Stanton VP Jr, Ridker PM. Chasman DI, et al. Among authors: ridker pm. JAMA. 2004 Jun 16;291(23):2821-7. doi: 10.1001/jama.291.23.2821. JAMA. 2004. PMID: 15199031

7

C-reactive protein levels and outcomes after statin therapy.

Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, McCabe CH, Pfeffer MA, Braunwald E; Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators. Ridker PM, et al. N Engl J Med. 2005 Jan 6;352(1):20-8. doi: 10.1056/NEJMoa042378. N Engl J Med. 2005. PMID: 15635109 Free article. Clinical Trial.

8

Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg/dl and C-reactive protein <2 mg/l: an analysis of the PROVE-IT TIMI-22 trial.

Ridker PM, Morrow DA, Rose LM, Rifai N, Cannon CP, Braunwald E. Ridker PM, et al. J Am Coll Cardiol. 2005 May 17;45(10):1644-8. doi: 10.1016/j.jacc.2005.02.080. Epub 2005 Apr 25. J Am Coll Cardiol. 2005. PMID: 15893181 Free article. Clinical Trial.

9

Tryptophanyl-tRNA synthetase gene polymorphisms and risk of incident myocardial infarction.

Zee RY, Hegener HH, Chasman DI, Ridker PM. Zee RY, et al. Among authors: ridker pm. Atherosclerosis. 2005 Jul;181(1):137-41. doi: 10.1016/j.atherosclerosis.2005.01.016. Epub 2005 Feb 17. Atherosclerosis. 2005. PMID: 15939065

10

Pharmacogenetics: the outlook for genetic testing in statin therapy.

Chasman DI, Ridker PM. Chasman DI, et al. Among authors: ridker pm. Nat Clin Pract Cardiovasc Med. 2005 Jan;2(1):2-3. doi: 10.1038/ncpcardio0071. Nat Clin Pract Cardiovasc Med. 2005. PMID: 16265332 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,135 results

Search Page